PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155 | -96.0% | 59 | -94.7% | 0.00% | – |
| Q2 2023 | $3,894 | +29.8% | 1,103 | 0.0% | 0.00% | – |
| Q1 2023 | $3,000 | +59900.0% | 1,103 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 1,103 | -61.3% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 2,849 | +27.6% | 0.00% | – |
| Q2 2022 | $6,000 | -98.5% | 2,232 | -98.4% | 0.00% | – |
| Q1 2022 | $412,000 | -5.7% | 142,881 | -0.4% | 0.00% | – |
| Q4 2021 | $437,000 | -58.1% | 143,497 | -3.7% | 0.00% | – |
| Q3 2021 | $1,044,000 | -27.9% | 148,940 | -5.6% | 0.00% | – |
| Q2 2021 | $1,448,000 | -9.8% | 157,699 | -4.5% | 0.00% | – |
| Q1 2021 | $1,605,000 | -22.6% | 165,138 | -18.3% | 0.00% | – |
| Q4 2020 | $2,074,000 | -16.2% | 202,129 | -17.9% | 0.00% | – |
| Q3 2020 | $2,476,000 | -12.8% | 246,336 | -9.5% | 0.00% | -100.0% |
| Q2 2020 | $2,840,000 | +332.3% | 272,273 | +250.0% | 0.00% | – |
| Q1 2020 | $657,000 | -14.6% | 77,794 | -11.5% | 0.00% | – |
| Q4 2019 | $769,000 | -22.7% | 87,908 | -4.8% | 0.00% | – |
| Q3 2019 | $995,000 | -14.9% | 92,310 | +0.3% | 0.00% | – |
| Q2 2019 | $1,169,000 | -71.4% | 92,055 | -12.7% | 0.00% | -100.0% |
| Q1 2019 | $4,090,000 | +94.6% | 105,453 | +2.1% | 0.00% | – |
| Q4 2018 | $2,102,000 | -58.7% | 103,302 | -6.9% | 0.00% | -100.0% |
| Q3 2018 | $5,086,000 | -14.9% | 110,926 | +9.8% | 0.00% | 0.0% |
| Q2 2018 | $5,974,000 | +124.5% | 101,014 | +158.3% | 0.00% | 0.0% |
| Q1 2018 | $2,661,000 | -75.3% | 39,107 | -64.1% | 0.00% | -50.0% |
| Q4 2017 | $10,779,000 | +12886.7% | 109,039 | +15344.6% | 0.00% | – |
| Q3 2017 | $83,000 | +72.9% | 706 | +28.8% | 0.00% | – |
| Q2 2017 | $48,000 | -98.5% | 548 | -99.4% | 0.00% | -100.0% |
| Q1 2017 | $3,174,000 | +15.4% | 85,338 | -4.7% | 0.00% | 0.0% |
| Q4 2016 | $2,750,000 | -65.1% | 89,569 | -23.8% | 0.00% | -50.0% |
| Q3 2016 | $7,882,000 | +14.1% | 117,547 | -49.3% | 0.00% | 0.0% |
| Q2 2016 | $6,907,000 | +33.2% | 231,875 | +31.4% | 0.00% | +100.0% |
| Q1 2016 | $5,185,000 | +6.5% | 176,530 | +184.3% | 0.00% | 0.0% |
| Q4 2015 | $4,869,000 | -74.4% | 62,102 | -75.4% | 0.00% | -80.0% |
| Q3 2015 | $19,019,000 | -44.9% | 252,382 | -14.6% | 0.01% | -37.5% |
| Q2 2015 | $34,505,000 | -36.3% | 295,536 | +28.8% | 0.01% | -33.3% |
| Q1 2015 | $54,172,000 | +50.5% | 229,436 | +20.7% | 0.01% | +50.0% |
| Q4 2014 | $35,991,000 | -45.3% | 190,160 | -31.1% | 0.01% | -50.0% |
| Q3 2014 | $65,835,000 | +113.5% | 275,959 | -40.9% | 0.02% | +100.0% |
| Q2 2014 | $30,834,000 | -30.1% | 467,180 | +10.4% | 0.01% | -33.3% |
| Q1 2014 | $44,085,000 | -9.8% | 423,335 | -10.3% | 0.01% | -14.3% |
| Q4 2013 | $48,868,000 | +97.4% | 472,018 | +2.3% | 0.01% | +100.0% |
| Q3 2013 | $24,756,000 | -23.8% | 461,354 | -37.0% | 0.01% | -30.0% |
| Q2 2013 | $32,509,000 | – | 732,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |